Evidence map›Paper›PMID 34202954›Full record

ArticleInternational journal of molecular sciences2021

Predicting Drug-Target Interactions Based on the Ensemble Models of Multiple Feature Pairs.

Cheng Wang, Jun Zhang, Peng Chen, Bing Wang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cheng WangDepartment of Computer Science & Technology, Tongji University, Shanghai 201804, China.ORCID 0000-0002-1267-6847
Jun ZhangInstitutes of Physical Science and Information Technology & School of Internet, Anhui University, Hefei 230601, China.
Peng ChenInstitutes of Physical Science and Information Technology & School of Internet, Anhui University, Hefei 230601, China.ORCID 0000-0002-5810-8159
Bing WangDepartment of Computer Science & Technology, Tongji University, Shanghai 201804, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Backgroud: The prediction of drug-target interactions (DTIs) is of great significance in drug development. It is time-consuming and expensive in traditional experimental methods. Machine learning can reduce the cost of prediction and is limited by the characteristics of imbalanced datasets and problems of essential feature selection.

methodsThe prediction method based on the Ensemble model of Multiple Feature Pairs (Ensemble-MFP) is introduced. Firstly, three negative sets are generated according to the Euclidean distance of three feature pairs. Then, the negative samples of the validation set/test set are randomly selected from the union set of the three negative sets in the validation set/test set. At the same time, the ensemble model with weight is optimized and applied to the test set.

resultsThe area under the receiver operating characteristic curve (area under ROC, AUC) in three out of four sub-datasets in gold standard datasets was more than 94.0% in the prediction of new drugs. The effectiveness of the proposed method is also shown with the comparison of state-of-the-art methods and demonstration of predicted drug-target pairs.

conclusionThe Ensemble-MFP can weigh the existing feature pairs and has a good prediction effect for general prediction on new drugs.

Indexed as

AlgorithmsModels, TheoreticalArea Under CurveDrug DevelopmentMachine LearningReproducibility of ResultsSupport Vector Machinedrug–target interactionsensemble model of Multiple Feature Pairs (Ensemble-MFP)model weight sumsupport vector machines

Identifiers

PMID34202954
PMCPMC8234024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.